Hjem › Melanom › Texas › Dallas
Melanom kliniske forsøg i Dallas, TX
20 studier for Melanom søger deltagere på steder i og omkring Dallas (inden for ca. 30 miles). Åbn et studie for at se, hvem der kan deltage, og hvordan man kontakter studieteamet.
Officiel studietekst (engelsk)
Rekrutterer til et studie her? Få det vist øverst på siden — $99 i 30 dage →
DESTINY-PANTUMOUR04
RekruttererObservationsstudie
- Research Site, Dallas
A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)
RekruttererFase 3
- Texas Oncology - Medical City, Dallas
- Texas Oncology, Dallas
Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis
RekruttererFase 1/2
- Baylor, Scott and White Research Institute, Dallas
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
RekruttererObservationsstudie
- UT Southwestern Medical Center, Dallas
DOC1021 Dendritic Cell Immunotherapy for Refractory Melanoma
RekruttererFase 1/2
- UT Southwestern, Dallas
Study of AMXT 1501 and DFMO in Combination With Standard Therapies in Advanced Solid Tumors
RekruttererFase 1/2
- Texas Oncology - Dallas SCRI, Dallas
Project: Every Child for Younger Patients With Cancer
RekruttererObservationsstudie
- Medical City Dallas Hospital, Dallas
- UT Southwestern/Simmons Cancer Center-Dallas, Dallas
A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)
RekruttererFase 1/2
- Texas Oncology, P.A., Dallas
A Study of Pembrolizumab (MK-3475) in Pediatric Participants With an Advanced Solid Tumor or Lymphoma (MK-3475-051/KEYNOTE-051)
RekruttererFase 1/2
- Call for Information (Investigational Site 0054), Dallas
Identification of Metabolic Phenotypes Associated With Melanoma Metastasis
RekruttererObservationsstudie
- University of Texas Southwestern Medical Center, Dallas
Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
RekruttererFase 1/2
- Mary Crowley Cancer Research, Dallas
Neoadjuvant Darovasertib in Primary Uveal Melanoma
RekruttererFase 3
- Texas Retina Associates - Dallas, Dallas
- University of Texas Southwestern Medical Center-5323 Harry Hines Blvd, Dallas
A Study of VET3-TGI in Patients With Solid Tumors
RekruttererFase 1
- Mary Crowley Cancer Research, Dallas
A Randomized, Phase 2/3 Study to Investigate the Efficacy and Safety of RP2 in Combination With Nivolumab in Immune Checkpoint Inhibitor-Naïve Adult Patients With Metastatic Uveal Melanoma
RekruttererFase 2/3
- UT Southwestern Medical Center, Dallas
A Phase 1/2 Clinical Trial to Assess the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of HMBD-501 in Patients With HER3-Expressing Solid Tumors
RekruttererFase 1/2
- Research Site, Dallas
A Phase 1 Study of JMT108 in Participants With Advanced Solid Tumors
RekruttererFase 1
- NEXT Dallas, Dallas
A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors
RekruttererFase 1/2
- Research Site 120, Dallas
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RekruttererObservationsstudie
- Massive Bio SYNERGY-AI site, Dallas
A Clinical Study of Intratumoral MVR-T3011 (T3011) Given as a Single Agent and in Combination With Intravenous Pembrolizumab in Participants With Advanced or Metastatic Solid Tumors
RekruttererFase 1/2
- Mary Crowley Cancer Research, Dallas
A First-in-human, Phase I, Open-label, Multicenter Study of NM1F(Anti-PVRIG) in Patients With Advanced Solid Tumors
RekruttererFase 1
- NEXT Oncology, Dallas, Dallas
Melanom forsøg i andre byer
- Houston, TX59 studier
- New York City, NY38 studier
- Los Angeles, CA34 studier
- Nashville, TN33 studier
- Pittsburgh, PA31 studier
- Boston, MA26 studier
- Philadelphia, PA23 studier
- San Francisco, CA22 studier
- Durham, NC21 studier
- Atlanta, GA21 studier
- St. Louis, MO21 studier
- Salt Lake City, UT21 studier
Andre studier i Dallas
- Brystkræft55 studier
- Ikke-småcellet lungecancer52 studier
- Metastatisk cancer42 studier
- Hjertesvigt42 studier
- Kræft (alle typer)37 studier
- Prostatakræft36 studier
- Colorektal kræft33 studier
- Overvægt30 studier
- Ægstockræft28 studier
- Blærecancer27 studier
- Lungecancer27 studier
- Livmoderslimhindekræft24 studier
Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.